US 12,247,053 B2
Peptides for inducing heterosubtypic influenza T cell responses
Daniel F. Hoft, St. Louis, MO (US); Christopher S. Eickhoff, St. Louis, MO (US); and Annie De Groot, Providence, RI (US)
Assigned to Saint Louis University, St. Louis, MO (US); and EpiVax, Inc., Providence, RI (US)
Appl. No. 17/288,133
Filed by Saint Louis University, St. Louis, MO (US); and EpiVax, Inc., Providence, RI (US)
PCT Filed Oct. 25, 2019, PCT No. PCT/US2019/057998
§ 371(c)(1), (2) Date Apr. 23, 2021,
PCT Pub. No. WO2020/086927, PCT Pub. Date Apr. 30, 2020.
Claims priority of provisional application 62/751,218, filed on Oct. 26, 2018.
Prior Publication US 2021/0380644 A1, Dec. 9, 2021
Int. Cl. A61K 39/39 (2006.01); A61K 9/19 (2006.01); A61K 39/145 (2006.01); C07K 14/11 (2006.01); A61K 39/00 (2006.01)
CPC C07K 14/11 (2013.01) [A61K 9/19 (2013.01); A61K 39/145 (2013.01); A61K 39/39 (2013.01); A61K 2039/5154 (2013.01)] 4 Claims
 
1. A peptide comprising the sequence of SEQ ID NO: 57 or 58.